Pfizer (Germany) Top Insiders

Pfizer Management Team Effectiveness

The company has return on total asset (ROA) of 0.0519 % which means that it generated a profit of $0.0519 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0858 %, meaning that it generated $0.0858 on every $100 dollars invested by stockholders. Pfizer's management efficiency ratios could be used to measure how well Pfizer manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Pfizer's Return On Tangible Assets are most likely to increase slightly in the upcoming years. The Pfizer's current Return On Capital Employed is estimated to increase to 0.22, while Return On Assets are projected to decrease to 0.04. At this time, Pfizer's Other Current Assets are most likely to increase significantly in the upcoming years. The Pfizer's current Return On Tangible Assets is estimated to increase to 0.10, while Total Current Assets are projected to decrease to roughly 50.2 B. The Pfizer's current Net Income Applicable To Common Shares is estimated to increase to about 37.9 B, while Common Stock Shares Outstanding is projected to decrease to roughly 4.5 B. Pfizer owns a total of 5.69 Billion outstanding shares. Over half of Pfizer's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Pfizer. Please watch out for any change in the institutional holdings of Pfizer Inc as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Pfizer in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pfizer, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Pfizer Workforce Comparison

Pfizer Profit Margins

The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.

Pfizer Inc Benchmark Summation

Pfizer Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Pfizer Inc often depends on how effective the management is. Pfizer management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pfizer management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pfizer management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.